Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald L Batisky

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
New American Academy of Pediatrics Hypertension GuidelineMarc B Lande, Donald L Batisky
The Pediatric Infectious Disease Journal|April 21, 2016
In Reply: Increased Prevalence of Elevated Blood Pressures in HIV-infected Children, Adolescents, and Young AdultsSam Chatterton-Kirchmeier, Andres F Camacho-Gonzalez, Donald L Batisky, et al.
Pharmacotherapy|August 19, 2003
Management of nephrotic syndrome in childrenRenee F Robinson, Milap C Nahata, John D Mahan, et al.
Paediatric Drugs|March 22, 2005
Pharmacologic treatment of chronic pediatric hypertensionRenee F Robinson, Milap C Nahata, Donald L Batisky, et al.
Journal of Clinical Pharmacology|January 31, 2009
Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertensionJeffrey Blumer, Donald L Batisky, Thomas Wells, et al.
Pediatric Nephrology (Berlin, Germany)|October 27, 2004
Body mass index in primary and secondary pediatric hypertensionRenee F Robinson, Donald L Batisky, John R Hayes, et al.
American Journal of Hypertension|August 2, 2005
Significance of heritability in primary and secondary pediatric hypertensionRenee F Robinson, Donald L Batisky, John R Hayes, et al.
The Pediatric Infectious Disease Journal|April 2, 2015
Increased prevalence of elevated blood pressures in HIV-infected children, adolescents and young adultsSam Chatterton-Kirchmeier, Andres F Camacho-Gonzalez, Courtney E McCracken, et al.
Psychosomatic Medicine|January 29, 2014
Blood pressure and school performanceMarc B Lande, Juan C Kupferman, Stephen R Hooper, et al.
Pharmacotherapy|March 5, 2004
Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescentsRenee E Robinson, Milap C Nahata, John R Hayes, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
New American Academy of Pediatrics Hypertension GuidelineMarc B Lande, Donald L Batisky
The Pediatric Infectious Disease Journal|April 21, 2016
In Reply: Increased Prevalence of Elevated Blood Pressures in HIV-infected Children, Adolescents, and Young AdultsSam Chatterton-Kirchmeier, Andres F Camacho-Gonzalez, Donald L Batisky, et al.
Pharmacotherapy|August 19, 2003
Management of nephrotic syndrome in childrenRenee F Robinson, Milap C Nahata, John D Mahan, et al.
Paediatric Drugs|March 22, 2005
Pharmacologic treatment of chronic pediatric hypertensionRenee F Robinson, Milap C Nahata, Donald L Batisky, et al.
Journal of Clinical Pharmacology|January 31, 2009
Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertensionJeffrey Blumer, Donald L Batisky, Thomas Wells, et al.
Pediatric Nephrology (Berlin, Germany)|October 27, 2004
Body mass index in primary and secondary pediatric hypertensionRenee F Robinson, Donald L Batisky, John R Hayes, et al.
American Journal of Hypertension|August 2, 2005
Significance of heritability in primary and secondary pediatric hypertensionRenee F Robinson, Donald L Batisky, John R Hayes, et al.
The Pediatric Infectious Disease Journal|April 2, 2015
Increased prevalence of elevated blood pressures in HIV-infected children, adolescents and young adultsSam Chatterton-Kirchmeier, Andres F Camacho-Gonzalez, Courtney E McCracken, et al.
Psychosomatic Medicine|January 29, 2014
Blood pressure and school performanceMarc B Lande, Juan C Kupferman, Stephen R Hooper, et al.
Pharmacotherapy|March 5, 2004
Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescentsRenee E Robinson, Milap C Nahata, John R Hayes, et al.
Pageof 3